News - Dainippon Sumitomo Pharma


Current filters:

Dainippon Sumitomo Pharma

Popular Filters

18 to 33 of 33 results

Dainippon Sumitomo partners with Nippon Shinyaku for urology drug AMP-986


Japanese drugmakers Dainippon Sumitomo Pharma (TYO: 4506) and Nippon Shinyaku (TYO: 4516) have concluded…

AMP-986Asia-PacificDainippon Sumitomo PharmaGenito-urinaryLicensingNippon ShinyakuPharmaceutical

Dainippon Sumitomo sets up subsidiary in Singapore


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has established a wholly-owned subsidiary in…

Asia-PacificDainippon Sumitomo PharmaMarkets & MarketingPharmaceuticalSunovion

Sunovion files two sNDAs for Latuda with FDA


Sunovion Pharmaceuticals, a US subsidiary of Japanese drug major Dainippon Sumitomo (TYO: 4506) has submitted…

Dainippon Sumitomo PharmaLatudaNeurologicalNorth AmericaPharmaceuticalRegulationSunovion

Dainippon Sumitomo files for approval of Calsed in China


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has submitted an imported drug registration…

Asia-PacificCalsedDainippon Sumitomo PharmaOncologyPharmaceuticalRegulation

Sunovion to acquire Elevation Pharma for up to $430 million


Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506) last week…

Dainippon Sumitomo PharmaElevation PharmaceuticalsEP-101Mergers & AcquisitionsPharmaceuticalRespiratory and PulmonarySunovion

Dainippon Sumitomo to set up DSP Cancer Institute


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says it plans to establish a new organization…

BiotechnologyDainippon Sumitomo PharmaManagementOncologyPharmaceuticalResearch

Japan's drug majors post mixed financial results


Japan's leading drugmakers rolled out financial results for the first fiscal quarter of 2013, ended June…

Daiichi SankyoDainippon Sumitomo PharmaFinancialKyowa Hakko KirinPharmaceuticalTakeda Pharmaceuticals

Watson confirms patent challenges for Xopenox HFA and Epiduo Gel


US generics drugmaker Watson Pharmaceuticals NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories…

Dainippon Sumitomo PharmaDermatologicalsEpiduo GelGaldermaGenericsLegalNorth AmericaRegulationRespiratory and PulmonarySunovionWatson PharmaceuticalsXopenox

Dainippon Sumitomo Pharma and Shionogi to co-market antihypertensive DSP-8153


Dainippon Sumitomo Pharma (DSP; TYO: 4506) has entered into a license accord with fellow Japanese drugmaker…

Amlodipine BesylateAsia-PacificCardio-vascularDainippon Sumitomo PharmaDSP-8153irbesartanLicensingMarkets & MarketingPharmaceuticalShionogi

US patent settlements of Xopenex and Lidoderm


US generics drug major Mylan (Nasdaq: MYL) has entered into a settlement agreement with Sunovion Pharmaceuticals,…

Dainippon Sumitomo PharmaEndo PharmaceuticalsGenericsLidodermMylan LaboratoriesNeurologicalNorth AmericaPatentsRespiratory and PulmonarySunovionWatson PharmaceuticalsXopenex

Dainippon Sumitomo's Latuda meets key endpoints in two Ph III trials in bipolar I depression


Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) Co., Ltd. (DSP) announced has results from two…

Dainippon Sumitomo PharmaLatudaNeurologicalPharmaceuticalResearch

Disappointing first-half FY 2011/12 results from Japanese drugmakers


There was a slew of financial results for the first half of fiscal year 2011 (to September 30, 2011)…

Daiichi SankyoDainippon Sumitomo PharmaFinancialMitsubishi TanabeNippon ChemipharPharmaceuticalShionogi

18 to 33 of 33 results

Back to top